Pages that link to "Q45734062"

The following pages link to Replication-incompetent adenoviral vaccine vector elicits effective anti-immunodeficiency-virus immunity (Q45734062):

Displaying 50 items.

• The use of nonhuman primate models in HIV vaccine development (Q21563403) ‎ (← links)
• The Global HIV/AIDS Vaccine Enterprise: scientific strategic plan (Q21563445) ‎ (← links)
• Vaccines for prevention of HIV infection (Q24200691) ‎ (← links)
• Protection of mice and poultry from lethal H5N1 avian influenza virus through adenovirus-based immunization (Q24538818) ‎ (← links)
• The hope for an HIV vaccine based on induction of CD8+ T lymphocytes--a review (Q24630490) ‎ (← links)
• The failed HIV Merck vaccine study: a step back or a launching point for future vaccine development? (Q24652185) ‎ (← links)
• The aftermath of the Merck's HIV vaccine trial (Q24654458) ‎ (← links)
• A randomised, double-blind, controlled vaccine efficacy trial of DNA/MVA ME-TRAP against malaria infection in Gambian adults (Q24804936) ‎ (← links)
• The HIV vaccine saga (Q24805100) ‎ (← links)
• Preclinical assessment of HIV vaccines and microbicides by repeated low-dose virus challenges (Q24812967) ‎ (← links)
• Methods and clinical development of adenovirus-vectored vaccines against mucosal pathogens (Q26750912) ‎ (← links)
• HIV-Host Interactions: Implications for Vaccine Design (Q26765966) ‎ (← links)
• Therapeutic vaccination and immunomodulation in the treatment of chronic hepatitis B: preclinical studies in the woodchuck (Q26828598) ‎ (← links)
• A brief history of the global effort to develop a preventive HIV vaccine (Q26851165) ‎ (← links)
• Nonhuman primate models for HIV/AIDS vaccine development (Q26861148) ‎ (← links)
• Induction of intestinal immunity by mucosal vaccines as a means of controlling HIV infection (Q27001897) ‎ (← links)
• Clinical development of candidate HIV vaccines: different problems for different vaccines (Q27005008) ‎ (← links)
• Vaccination with Replication Deficient Adenovectors Encoding YF-17D Antigens Induces Long-Lasting Protection from Severe Yellow Fever Virus Infection in Mice (Q27303766) ‎ (← links)
• Vaccination-induced noncytolytic effects in the acute phase of SHIV infection (Q27313589) ‎ (← links)
• Vaccination against heterologous R5 clade C SHIV: prevention of infection and correlates of protection (Q27332360) ‎ (← links)
• An adenovirus type 5 (Ad5) amplicon-based packaging cell line for production of high-capacity helper-independent deltaE1-E2-E3-E4 Ad5 vectors (Q27469506) ‎ (← links)
• Tetraspanins in viral infections: a fundamental role in viral biology? (Q27470936) ‎ (← links)
• Comparative vaccine studies in HLA-A2.1-transgenic mice reveal a clustered organization of epitopes presented in hepatitis C virus natural infection (Q27472916) ‎ (← links)
• A novel adenovirus type 6 (Ad6)-based hepatitis C virus vector that overcomes preexisting anti-ad5 immunity and induces potent and broad cellular immune responses in rhesus macaques (Q27472927) ‎ (← links)
• A Heterologous DNA Prime-Venezuelan Equine Encephalitis Virus Replicon Particle Boost Dengue Vaccine Regimen Affords Complete Protection from Virus Challenge in Cynomolgus Macaques (Q27484994) ‎ (← links)
• Increased Immunogenicity of a DNA-Launched Venezuelan Equine Encephalitis Virus-Based Replicon DNA Vaccine (Q27485003) ‎ (← links)
• A Tetravalent Dengue Vaccine Based on a Complex Adenovirus Vector Provides Significant Protection in Rhesus Monkeys against All Four Serotypes of Dengue Virus (Q27486406) ‎ (← links)
• Replication-Defective Adenoviral Vaccine Vector for the Induction of Immune Responses to Dengue Virus Type 2 (Q27487570) ‎ (← links)
• Different Vaccine Vectors Delivering the Same Antigen Elicit CD8+ T Cell Responses with Distinct Clonotype and Epitope Specificity (Q27646554) ‎ (← links)
• Additives for vaccine storage to improve thermal stability of adenoviruses from hours to months (Q27980656) ‎ (← links)
• Application of InChI to curate, index, and query 3-D structures (Q28133308) ‎ (← links)
• Immunopathogenesis and immunotherapy in AIDS virus infections (Q28183667) ‎ (← links)
• Overcoming immunity to a viral vaccine by DNA priming before vector boosting (Q28217213) ‎ (← links)
• Annulling a dangerous liaison: vaccination strategies against AIDS and tuberculosis (Q28243702) ‎ (← links)
• Prevention of SIV rectal transmission and priming of T cell responses in macaques after local pre-exposure application of tenofovir gel (Q28473376) ‎ (← links)
• Identification of targets of CD8⁺ T cell responses to malaria liver stages by genome-wide epitope profiling (Q28704543) ‎ (← links)
• Safety and immunogenicity of an HIV-1 gag DNA vaccine with or without IL-12 and/or IL-15 plasmid cytokine adjuvant in healthy, HIV-1 uninfected adults (Q28740321) ‎ (← links)
• Vaccination with Ad5 vectors expands Ad5-specific CD8 T cells without altering memory phenotype or functionality (Q28744027) ‎ (← links)
• Priming immunization with DNA augments immunogenicity of recombinant adenoviral vectors for both HIV-1 specific antibody and T-cell responses (Q28749120) ‎ (← links)
• Efficacy assessment of a cell-mediated immunity HIV-1 vaccine (the Step Study): a double-blind, randomised, placebo-controlled, test-of-concept trial (Q28972526) ‎ (← links)
• Multifunctional TH1 cells define a correlate of vaccine-mediated protection against Leishmania major (Q29619125) ‎ (← links)
• T-cell quality in memory and protection: implications for vaccine design (Q30014840) ‎ (← links)
• Production of adenovirus vectors and their use as a delivery system for influenza vaccines (Q30226988) ‎ (← links)
• Expression and Immunogenicity of Sequence-Modified Human Immunodeficiency Virus Type 1 Subtype BpolandgagpolDNA Vaccines (Q30332833) ‎ (← links)
• Innate and adaptive mucosal immunity in protection against HIV infection. (Q30332881) ‎ (← links)
• Sensitivity Analysis for the Assessment of Causal Vaccine Effects on Viral Load in HIV Vaccine Trials (Q30336405) ‎ (← links)
• Prospects for an AIDS vaccine: three big questions, no easy answers. (Q30342038) ‎ (← links)
• Protection against multiple influenza A subtypes by vaccination with highly conserved nucleoprotein. (Q30351034) ‎ (← links)
• HIV-1 variable loop 2 and its importance in HIV-1 infection and vaccine development (Q30355260) ‎ (← links)
• Modified vaccinia virus Ankara encoding influenza virus hemagglutinin induces heterosubtypic immunity in macaques. (Q30366666) ‎ (← links)